The Patent Finder

Synthekine, Inc.

23 patents currently held · Updated Nov 17, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2041
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jul 2 to 16, 2027 · next Jul 2

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 19, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 11,491,205Biased IL2 Muteins Methods and Compositions
In force
 · High confidence
In forceHigh confidence
US 12,734,215Biased IL2 Muteins Methods and Compositions
In force
 · High confidence
In forceHigh confidence
US 11,648,296IL-2 Orthologs and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 12,157,773IL27RAlpha binding molecules and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,209,132Compositions and Methods Related to IL27 Receptor Binding
In force
 · Low confidence
In forceLow confidence
US 11,859,001IL12RB1-Binding molecules and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,012,457IL23R binding molecules and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,018,085Interferon-gamma R2 (IFNGR2) binding molecules comprising single-domain antibodies and method of use thereof to treat autoimmune and inflammatory diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,122,839Ifngr Binding Synthetic Cytokines and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 12,139,545IL10 receptor binding molecules and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

13 pending · 2 abandoned · 11 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited